Literature DB >> 25982240

Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.

Anca-Irina Grigoriu1, Mickael Dinomais2, Olivier Rémy-Néris3, Sylvain Brochard3.   

Abstract

OBJECTIVE: To conduct a systematic review of the impact of different injection-guiding techniques on the effectiveness of botulinum toxin type A (BoNT-A) for the treatment of focal spasticity and dystonia. DATA SOURCES: MEDLINE via PubMed, Academic Search Premier, PASCAL, The Cochrane Library, Scopus, SpringerLink, Web of Science, EM Premium, and PsycINFO. STUDY SELECTION: Two reviewers independently selected studies based on predetermined inclusion criteria. DATA EXTRACTION: Data relating to the aim were extracted. Methodological quality was graded independently by 2 reviewers using the Physiotherapy Evidence Database assessment scale for randomized controlled trials (RCTs) and the Downs and Black evaluation tool for non-RCTs. Level of evidence was determined using the modified Sackett scale. DATA SYNTHESIS: Ten studies were included. Seven were randomized. There was strong evidence (level 1) that instrumented guiding (ultrasonography [US], electrical stimulation [ES], electromyogram [EMG]) was more effective than manual needle placement for the treatment of spasmodic torticollis, upper limb spasticity, and spastic equinus in patients with stroke, and spastic equinus in children with cerebral palsy. Three studies provided strong evidence (level 1) of similar effectiveness of US and ES for upper and lower limb spasticity in patients with stroke, and spastic equinus in children with cerebral palsy, but there was poor evidence or no available evidence for EMG or other instrumented techniques.
CONCLUSIONS: These results strongly recommend instrumented guidance of BoNT-A injection for the treatment of spasticity in adults and children (ES or US), and of focal dystonia such as spasmodic torticollis (EMG). No specific recommendations can be made regarding the choice of instrumented guiding technique, except that US appears to be more effective than ES for spastic equinus in adults with stroke.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Botulinum toxins; Electric stimulation; Electromyography; Injections, intramuscular; Palpation; Rehabilitation; Ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 25982240     DOI: 10.1016/j.apmr.2015.05.002

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  18 in total

1.  A Pilot Randomized Controlled Trial of Botulinum Toxin Treatment Combined with Robot-Assisted Therapy, Mirror Therapy, or Active Control Treatment in Patients with Spasticity Following Stroke.

Authors:  Jen-Wen Hung; Chu-Ling Yen; Ku-Chou Chang; Wei-Chi Chiang; I-Ching Chuang; Ya-Ping Pong; Wen-Chi Wu; Ching-Yi Wu
Journal:  Toxins (Basel)       Date:  2022-06-17       Impact factor: 5.075

2.  Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey.

Authors:  Giorgio Sandrini; A Baricich; C Cisari; Stefano Paolucci; Nicola Smania; A Picelli
Journal:  Funct Neurol       Date:  2018 Jan/Mar

3.  Efficacy of two injection-site localisation techniques for botulinum toxin injections: a single-blind, crossover, randomised trial protocol among adults with hemiplegia due to stroke.

Authors:  Claire Morel; Isabelle Hauret; Nicolas Andant; Armand Bonnin; Bruno Pereira; Emmanuel Coudeyre
Journal:  BMJ Open       Date:  2016-11-15       Impact factor: 2.692

Review 4.  Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.

Authors:  Katharine E Alter; Barbara I Karp
Journal:  Toxins (Basel)       Date:  2017-12-28       Impact factor: 4.546

Review 5.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

6.  Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.

Authors:  Tiina Rekand; Bo Biering-Sörensen; Jun He; Ole Jakob Vilholm; Peter Brøgger Christensen; Trandur Ulfarsson; Roger Belusa; Torbjörn Ström; Peter Myrenfors; Pascal Maisonobe; Torben Dalager
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

7.  Efficacy and Optimal Dose of Botulinum Toxin A in Post-Stroke Lower Extremity Spasticity: A Systematic Review and Meta-Analysis.

Authors:  Thanh-Nhan Doan; Mei-Ying Kuo; Li-Wei Chou
Journal:  Toxins (Basel)       Date:  2021-06-18       Impact factor: 4.546

8.  Ultrasonographic Evaluation of Botulinum Toxin Injection Site for the Medial Approach to Tibialis Posterior Muscle in Chronic Stroke Patients with Spastic Equinovarus Foot: An Observational Study.

Authors:  Alessandro Picelli; Alessio Baricich; Elena Chemello; Nicola Smania; Carlo Cisari; Marialuisa Gandolfi; Nicoletta Cinone; Maurizio Ranieri; Andrea Santamato
Journal:  Toxins (Basel)       Date:  2017-11-18       Impact factor: 4.546

9.  Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.

Authors:  You Gyoung Yi; Keewon Kim; Youbin Yi; Young-Ah Choi; Ja-Ho Leigh; Moon Suk Bang
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

10.  Brain functional changes in patients with botulism after illegal cosmetic injections of botulinum toxin: A resting-state fMRI study.

Authors:  Ge-Fei Li; Shiyu Ban; Mengxing Wang; Jilei Zhang; Haifeng Lu; Yan-Hui Shi; Xin-Wei He; Yi-Lan Wu; Peng Peng; Yi-Sheng Liu; Mei-Ting Zhuang; Rong Zhao; Xiao-Lei Shen; Qiang Li; Jian-Ren Liu; Xiaoxia Du
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.